Long non-coding RNA AK006774 inhibits cardiac ischemia-reperfusion injury via sponging miR-448

References

• Hausenloy DJ, Yellon DM Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13:193–209.
   PubMed Web of Science ®Google Scholar
• McLaughlin S, McNeill B, Podrebarac J, et al. Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction. Nat Commun. 2019;10:4866.
   PubMed Web of Science ®Google Scholar
• Heusch G, Gersh BJ The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38:774–784.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92–100.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang D, Yu L, et al. Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury. Bioengineered. 2019;10:121–132.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiao L, Sun L, et al. LncRNA ZFAS1 as a SERCA2a inhibitor to cause intracellular Ca(2+) overload and contractile dysfunction in a mouse model of myocardial infarction. Circ Res. 2018;122:1354–1368.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Zhang M, Zhang M, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11:53–60.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu CY, Zhou LY, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779.
   PubMed Web of Science ®Google Scholar
• Su Q, Liu Y, Lv X, et al. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy. J Mol Cell Cardiol. 2019;133:12–25.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Chen Jjiang H, Jiang H, et al. LncRNA H19 ameliorates myocardial ischemia-reperfusion injury by targeting miR-22-3P. Int J Cardiol. 2019;278:224.
   PubMed Web of Science ®Google Scholar
• Liu CY, Zhang YH, Li R, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9:29.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11:11–18.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang B, Zhou Q, et al. MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7. Cell Death Dis. 2018;9:769.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu F, Liu CY, et al. The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873. Cell Death Differ. 2016;23:1394–1405.
   PubMed Web of Science ®Google Scholar
• Liu CY, Zhang YH, Li RB, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9:29.
   PubMed Web of Science ®Google Scholar
• Wu N, Zhang X, Bao Y, et al. Down-regulation of GAS5 ameliorates myocardial ischaemia/reperfusion injury via the miR-335/ROCK1/AKT/GSK-3β axis. J Cell Mol Med. 2019;23(12):8420–8431.
   PubMed Web of Science ®Google Scholar
• Lu L, Ma J, Tang J, et al. Irisin attenuates myocardial ischemia/reperfusion-induced cardiac dysfunction by regulating ER-mitochondria interaction through a mitochondrial ubiquitin ligase-dependent mechanism. Clin Transl Med. 2020;10:e166.
   PubMed Web of Science ®Google Scholar
• Wu F, Huang W, Tan Q, et al. ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1. Cell Death Dis. 2021;12:614.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang H, Zheng Y, et al. The long noncoding RNA MALAT1 induces tolerogenic dendritic cells and regulatory T cells via miR155/dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin/IL10 axis. Front Immunol. 2018;9:1847.
   PubMed Web of Science ®Google Scholar
• Wang S, Yu W, Chen J, et al. LncRNA MALAT1 sponges miR-203 to promote inflammation in myocardial ischemia-reperfusion injury. Int J Cardiol. 2018;268:245.
   PubMed Web of Science ®Google Scholar
• Yu SY, Dong B, Tang L, et al. LncRNA MALAT1 sponges miR-133 to promote NLRP3 inflammasome expression in ischemia-reperfusion injured heart. Int J Cardiol. 2018;254:50.
   PubMed Web of Science ®Google Scholar
• Liang H, Pan Z, Zhao X, et al. LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d. Theranostics. 2018;8:1180–1194.
   PubMed Web of Science ®Google Scholar
• Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO. Int J Biol Macromol. 2018;118:24–30.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu K, Yang B, et al. Knockdown of Linc00052 alleviated spinal nerve ligation-triggered neuropathic pain through regulating miR-448 and JAK1. J Cell Physiol. 2020;235:6528–6535.
   PubMed Web of Science ®Google Scholar
• Gao J, Feng X, Wang F, et al. microRNA-448 inhibits the progression of non-small-cell lung cancer through regulating IRS2. J Cell Biochem. 2019;120:13453–13463.
   PubMed Web of Science ®Google Scholar
• Jin J, Wu Y, Zhou D, et al. miR448 targets Rab2B and is pivotal in the suppression of pancreatic cancer. Oncol Rep. 2018;40:1379–1389.
   PubMed Web of Science ®Google Scholar
• Su HY, Lin ZY, Peng W, et al. MiR-448 downregulates CTTN to inhibit cell proliferation and promote apoptosis in glioma. Eur Rev Med Pharmacol Sci. 2018;22:3847–3854.
   PubMed Web of Science ®Google Scholar
• Wang Y, Pang QJ, Liu JT, et al. Down-regulated miR-448 relieves spinal cord ischemia/reperfusion injury by up-regulating SIRT1. Braz J Med Biol Res. 2018;51:e7319.
   PubMed Web of Science ®Google Scholar
• Wang M, Luo J, Wan L, et al. Screening genes associated with myocardial infarction and transverse aortic constriction using a combined analysis of miRNA and mRNA microarray. Gene. 2015;571:245–248.
   PubMed Web of Science ®Google Scholar
• Yang ZC, Qu ZH, Yi MJ, et al. MiR-448-5p inhibits TGF-beta1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma. J Cell Physiol. 2019;234:8804–8814.
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhou Y, Sun A, et al. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. J Cell Physiol. 2018;233:8558–8566.
   PubMed Web of Science ®Google Scholar
• Li B, Ge L, Li M, et al. miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells. Am J Transl Res. 2016;8:3013–3022.
   PubMed Web of Science ®Google Scholar
• Aird D, Teng T, Huang C, et al. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators. Nat Commun. 2019;10:137.
   PubMed Web of Science ®Google Scholar
• Valentin R, Grabow S, Davids MS The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood. 2018;132:1248–1264.
   PubMed Web of Science ®Google Scholar
• Hu L, Xu Y, Wang Q, et al. Yiqi Huoxue Recipe inhibits cardiomyocyte apoptosis caused by heart failure through Keap1/Nrf2/HIF-1α signaling pathway. Bioengineered. 2021;12:969–978.
   PubMed Web of Science ®Google Scholar
• Davids MS. Targeting BCL-2 in B-cell lymphomas. Blood. 2017;130:1081–1088.
   PubMed Web of Science ®Google Scholar
• Llambi F, Wang YM, Victor V, et al. BOK is a non-canonical BCL-2 family effector of apoptosis regulated by ER-Associated degradation. Cell. 2016;165:421–433.
   PubMed Web of Science ®Google Scholar
• Delbridge AR, Grabow S, Strasser A, et al. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16:99–109.
   PubMed Web of Science ®Google Scholar
• Hata AN, Engelman JA, et al. The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 2015;5:475–487.
   PubMed Web of Science ®Google Scholar